ABCL-429 Epcoritamab + R-CHOP in Patients With Previously Untreated (1L) High-Risk Diffuse Large B-Cell Lymphoma, Including Double-Hit/Triple-Hit Lymphoma: Updated EPCORE NHL-2 Data
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
ABCL,bispecific,diffuse large B-cell lymphoma,hematologic malignancy,non-Hodgkin lymphoma,Phase II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要